- Home
- GNLX vs L Comparison
GNLX vs L Comparison
Compare GNLX & L Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- L
- Stock Information
- Founded
- GNLX 2001
- L 1969
- Country
- GNLX United States
- L United States
- Employees
- GNLX N/A
- L N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- L Property-Casualty Insurers
- Sector
- GNLX Health Care
- L Finance
- Exchange
- GNLX Nasdaq
- L Nasdaq
- Market Cap
- GNLX 112.5M
- L 18.5B
- IPO Year
- GNLX 2023
- L N/A
- Fundamental
- Price
- GNLX $3.44
- L $90.47
- Analyst Decision
- GNLX Strong Buy
- L
- Analyst Count
- GNLX 4
- L 0
- Target Price
- GNLX $17.75
- L N/A
- AVG Volume (30 Days)
- GNLX 152.2K
- L 929.9K
- Earning Date
- GNLX 08-13-2025
- L 07-28-2025
- Dividend Yield
- GNLX N/A
- L 0.28%
- EPS Growth
- GNLX N/A
- L N/A
- EPS
- GNLX N/A
- L 6.09
- Revenue
- GNLX N/A
- L $17,773,000,000.00
- Revenue This Year
- GNLX N/A
- L N/A
- Revenue Next Year
- GNLX N/A
- L N/A
- P/E Ratio
- GNLX N/A
- L $14.87
- Revenue Growth
- GNLX N/A
- L 8.71
- 52 Week Low
- GNLX $1.60
- L $75.16
- 52 Week High
- GNLX $5.89
- L $92.85
- Technical
- Relative Strength Index (RSI)
- GNLX 65.71
- L 51.14
- Support Level
- GNLX $2.80
- L $89.42
- Resistance Level
- GNLX $3.61
- L $92.85
- Average True Range (ATR)
- GNLX 0.22
- L 1.35
- MACD
- GNLX 0.05
- L -0.08
- Stochastic Oscillator
- GNLX 80.23
- L 36.92
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.